Table 9 Adverse events reported during study.
Adverse drug reactions | DLX- PG n = 30 (%) | PG-NT n = 30 (%) | Total |
|---|---|---|---|
Headache | 4 (13.33%) | 1 (3.33%) | 5 |
Abnormal dream & sleep disorder | 1 (3.33%) | 1 (3.33%) | 2 |
Weight gain | 1 (3.33%) | 2 (6.67%) | 3 |
Blurred vision | 1 (3.33%) | - | 1 |
Peripheral edema | 1 (3.33%) | - | 1 |
Uncoordinated body movements | 1 (3.33%) | 1 (3.33%) | 2 |
Total | 9 | 5 | 14 |
Percentage | 30% | 16.67% | 23.33% |
